Victory Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.3K | Sell |
18,022
-187
| -1% | -$387 | ﹤0.01% | 2406 |
|
|
2025
Q1 | $40.1K | Sell |
18,209
-471
| -3% | -$1.04K | ﹤0.01% | 2385 |
|
|
2024
Q4 | $28.6K | Buy |
18,680
+398
| +2% | +$609 | ﹤0.01% | 2429 |
|
|
2024
Q3 | $36.4K | Buy |
18,282
+270
| +1% | +$537 | ﹤0.01% | 2410 |
|
|
2024
Q2 | $63K | Sell |
18,012
-750
| -4% | -$2.63K | ﹤0.01% | 2344 |
|
|
2024
Q1 | $52K | Sell |
18,762
-1,167
| -6% | -$3.23K | ﹤0.01% | 2375 |
|
|
2023
Q4 | $33.9K | Buy |
19,929
+4,617
| +30% | +$7.85K | ﹤0.01% | 2473 |
|
|
2023
Q3 | $15.8K | Buy |
15,312
+2,424
| +19% | +$2.5K | ﹤0.01% | 2461 |
|
|
2023
Q2 | $15K | Sell |
12,888
-299
| -2% | -$347 | ﹤0.01% | 2465 |
|
|
2023
Q1 | $19.9K | Sell |
13,187
-171
| -1% | -$258 | ﹤0.01% | 2510 |
|
|
2022
Q4 | $33.4K | Buy |
13,358
+1,705
| +15% | +$4.26K | ﹤0.01% | 2485 |
|
|
2022
Q3 | $49K | Sell |
11,653
-1,161
| -9% | -$4.88K | ﹤0.01% | 2568 |
|
|
2022
Q2 | $36K | Sell |
12,814
-44
| -0.3% | -$124 | ﹤0.01% | 2578 |
|
|
2022
Q1 | $58K | Sell |
12,858
-1,081
| -8% | -$4.88K | ﹤0.01% | 2583 |
|
|
2021
Q4 | $127K | Sell |
13,939
-430
| -3% | -$3.92K | ﹤0.01% | 2544 |
|
|
2021
Q3 | $154K | Sell |
14,369
-714
| -5% | -$7.65K | ﹤0.01% | 2569 |
|
|
2021
Q2 | $234K | Buy |
15,083
+1,125
| +8% | +$17.5K | ﹤0.01% | 2495 |
|
|
2021
Q1 | $226K | Sell |
13,958
-349
| -2% | -$5.65K | ﹤0.01% | 2497 |
|
|
2020
Q4 | $303K | Buy |
14,307
+730
| +5% | +$15.5K | ﹤0.01% | 2281 |
|
|
2020
Q3 | $201K | Buy |
+13,577
| New | +$201K | ﹤0.01% | 2286 |
|